BE822930A - Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles - Google Patents

Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles

Info

Publication number
BE822930A
BE822930A BE151140A BE151140A BE822930A BE 822930 A BE822930 A BE 822930A BE 151140 A BE151140 A BE 151140A BE 151140 A BE151140 A BE 151140A BE 822930 A BE822930 A BE 822930A
Authority
BE
Belgium
Prior art keywords
elimination
pharmaceutical
influence
setting
calcium salts
Prior art date
Application number
BE151140A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE822930A publication Critical patent/BE822930A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE151140A 1974-02-04 1974-12-04 Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles BE822930A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2405254A DE2405254C2 (de) 1974-02-04 1974-02-04 Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper

Publications (1)

Publication Number Publication Date
BE822930A true BE822930A (fr) 1975-06-04

Family

ID=5906567

Family Applications (1)

Application Number Title Priority Date Filing Date
BE151140A BE822930A (fr) 1974-02-04 1974-12-04 Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles

Country Status (11)

Country Link
US (1) US3962432A (xx)
JP (1) JPS50107148A (xx)
AT (1) AT332557B (xx)
BE (1) BE822930A (xx)
CA (1) CA1033666A (xx)
CH (1) CH610201A5 (xx)
DE (1) DE2405254C2 (xx)
FR (1) FR2259615B1 (xx)
GB (1) GB1435885A (xx)
IT (1) IT1058296B (xx)
NL (1) NL176999B (xx)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
DE2553963A1 (de) * 1975-12-01 1977-06-08 Henkel & Cie Gmbh Pharmazeutische praeparate zur behandlung von stoerungen des calciumstoffwechsels
DE2745083C2 (de) 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
FR2489334A1 (fr) * 1980-09-04 1982-03-05 Vysoka Skola Chem Tech Acide 6-amino-1-hydroxyhexilidene-diphosphonique, ses sels, et procede pour l'obtention de ces produits
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
IT1201087B (it) * 1982-04-15 1989-01-27 Gentili Ist Spa Bifosfonati farmacologicamente attivi,procedimento per la loro preparazione e relative composizioni farmaceutiche
DE19675047I2 (de) * 1982-04-15 2003-06-12 Gentili Ist Spa Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure
US4446052A (en) * 1982-05-17 1984-05-01 The Procter & Gamble Company Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
JPS61500727A (ja) * 1983-12-21 1986-04-17 インステイテユト　オルガニチエスコイ　イ　フイジチエスコイ　ヒミイ　イメニ　ア−．イエ−．アルブゾバ　カザンスコゴ　フイリアラ　アカデミイ　ナウク　エスエスエスエ−ル 抗アシド−シス医薬製剤
IT1195993B (it) * 1984-01-12 1988-11-03 Gentili Ist Spa Forme farmaceutiche a base di difosfonati
FR2558837B1 (fr) * 1984-01-26 1986-06-27 Sanofi Sa Derives de l'acide methylenediphosphonique, procede d'obtention et medicaments antirhumatismaux les contenant
DE3425812A1 (de) * 1984-07-13 1986-01-16 Deutsches Krebsforschungszentrum, 6900 Heidelberg Neue 1-hydroxy-1,1-diphosphonsaeureverbindungen, verfahren zu ihrer herstellung und pharmakologische zubereitungen, insbesondere zur behandlung von knochentumoren
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
DE3434667A1 (de) * 1984-09-21 1986-04-03 Henkel KGaA, 4000 Düsseldorf 4-dimethylamino-1-hydroxybutan-1,1-diphosphonsaeure, deren wasserloesliche salze, verfahren zu ihrer herstellung sowie ihre verwendung
US4575456A (en) * 1984-11-30 1986-03-11 Colgate-Palmolive Company Gel dentifrice of desirable consistency
IT1187828B (it) * 1985-05-24 1987-12-23 Gentili Ist Spa Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
DE3724654A1 (de) * 1987-07-25 1989-02-02 Henkel Kgaa Hydroxyacetonitrildiphosphonsaeure, verfahren zu ihrer herstellung und ihre verwendung
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
US5139786A (en) * 1989-07-07 1992-08-18 Ciba-Geigy Corporation Topical formulations
MX21453A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
US5227506A (en) * 1989-09-06 1993-07-13 Merck & Co., Inc. Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5270365A (en) * 1991-12-17 1993-12-14 Merck & Co., Inc. Prevention and treatment of periodontal disease with alendronate
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
TW237386B (xx) 1992-04-15 1995-01-01 Ciba Geigy
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
EP0753523A1 (en) 1995-07-10 1997-01-15 Gador S.A. Amino-substituted bisphosphonic acids
WO1997012619A1 (en) * 1995-09-29 1997-04-10 Novartis Ag Method of treating the navicular disease in horses
EP1135397B1 (en) 1998-12-10 2003-04-23 Aesgen, Inc. Method for preparation of disodium pamidronate
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
US6677320B2 (en) 2000-01-20 2004-01-13 Hoffmann-La Roches Inc. Parenteral bisphosphonate composition with improved local tolerance
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
KR100593510B1 (ko) * 2001-01-23 2006-06-28 가도르 에스.에이. 골의 대사성 질병의 예방 및/또는 치료를 위한비스포스포네이트 함유 조성물, 그 조성물의 제조방법 및그의 이용
HUP0400087A3 (en) * 2001-05-02 2007-05-29 Sicor Inc Injectable pamidroate disodium
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
TWI315982B (en) * 2001-07-19 2009-10-21 Novartis Ag Combinations comprising epothilones and pharmaceutical uses thereof
KR100638122B1 (ko) * 2001-12-21 2006-10-24 더 프록터 앤드 갬블 캄파니 골 장애의 치료 방법
PT1506041E (pt) * 2002-05-10 2007-12-28 Hoffmann La Roche Ácido ibandrónico para o tratamento e a prevenção da osteoporose
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
SI1790347T1 (sl) 2002-12-20 2015-03-31 F. Hoffmann-La Roche Ag Formulacija z visokim odmerkom ibandronata
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
EP2136814A4 (en) * 2007-03-21 2012-05-30 Univ Duke MEDICAL KITS AND FORMULATIONS FOR PREVENTING, TREATING OR REDUCING SECONDARY FRACTURES FROM A PREVIOUS FRACTURE
HUE025737T2 (en) 2009-09-01 2016-05-30 Univ Duke Bisphosphonate compositions and methods for treating heart failure
BR112012026098A2 (pt) 2010-04-16 2016-11-22 Novartis Ag métodos e composições para melhorar a osseointegração de implante.
JP6261512B2 (ja) 2011-11-16 2018-01-17 デューク ユニバーシティ 心機能障害を治療及び／又は低減するためのビスホスホネート組成物並びに方法
PL407922A1 (pl) 2014-04-16 2015-10-26 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Nowe bisfosfoniany i ich zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9776A (en) * 1967-12-11 1976-03-17 M Francis Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use
DE2130794C3 (de) * 1971-06-22 1974-07-11 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von l-Hydroxy-S-amino-propan-ljl-diphosphonsäure

Also Published As

Publication number Publication date
GB1435885A (en) 1976-05-19
DE2405254A1 (de) 1975-08-14
AT332557B (de) 1976-10-11
IT1058296B (it) 1982-04-10
DE2405254C2 (de) 1982-05-27
ATA76175A (de) 1976-01-15
NL7414947A (nl) 1975-08-06
NL176999B (nl) 1985-02-18
JPS50107148A (xx) 1975-08-23
FR2259615B1 (xx) 1978-07-21
CH610201A5 (xx) 1979-04-12
FR2259615A1 (xx) 1975-08-29
US3962432A (en) 1976-06-08
CA1033666A (en) 1978-06-27

Similar Documents

Publication Publication Date Title
BE822930A (fr) Preparations pharmaceutiques ou cosmetiques destinees a influencer la fixation et l'elimination de sels de calcium peu solubles
FR2290912A1 (fr) Formulations pharmaceutiques contenant de la l-dopa ou ses derives
BE822929A (fr) Preparations pharmaceutiques destinees a influencer la fixationet l'elimination de sels peu solubles de calcium
IT1104643B (it) Sistema terapeutico in forma di cerotto o simile per la somministrazione di clonidina per via transdermica e procedimento per la sua preparazione
BE804417A (fr) Composition de shampooing de detergence controlee et procede d'obtention
BE807110A (fr) Procede de preparation de poly-n-vinylpyrrolidone-2 ou de copolymeres de poly-n-vinypyrrolidone et d'autres n-vinyllactames insolubles et peu susceptibles de gonflement
BE838642A (fr) Utilisation de perfluoroalcane-sulfonamides et/ou de sels d'ammonium et/ou de cyclimmonium d'acides perfluoroalcane-sulfoniques comme agents de demoulage
FR2299853A1 (fr) Bandage therapeutique pour l'administration de scopolamine par voie percutanee
BE806343A (fr) Implant d'os
BE835902A (fr) L'acide 4 - (e) - et 4 - (z) - 7 - methyl - 9 - (2,6,6 - trimethyl -1- cyclohexene -1- yle) - nona - 2,4,6,8 - tetraenecarboxylique et ses derives, leurpreparation et leur utilisation dans des compositions pharmaceutiques
BE803771A (fr) Derives de l'acide 4-hydroxy-3,5-di-alcoyl-phenyl-propionique, leur preparation et leur application
BE845089A (fr) Article a l'etat de gel ou de consistance cireuse
FR2343730A1 (fr) Derives d'acide amidinoformique ou d'acide amidinosulfinique, leur preparation et compositions pharmaceutiques les contenant
BE803754A (fr) Nouvelles compositions pharmaceutiques a base d'antibiotiques et d'acide pyrrolidone-carboxylique ou de ses derives
FR2288724A1 (fr) Preparation de resorcinols a partir d'acides d-cetocarboxyliques ou de leurs lactones
BE858273A (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile
BE854137A (fr) Composition pharmaceutiques de traitement de l'acne
BE796999A (fr) Derives d'acide octanoique et leur preparation
FR2619008B1 (fr) Utilisation de synergistines dans des compositions pharmaceutiques ou cosmetiques anti-acneiques
BE838880A (fr) Hydrazides d'acide (2-oxo-pyrrolidone-1)-acetique, procedes de preparation et preparations pharmaceutiques les contenant
BE816369R (fr) Derives de sels d'ammonium d'acides amino-benzoiques substitues et leur preparation
BE789088A (fr) Derives meso-ioniques de la 1,3,4-thiadiazole-imine-(5), leur preparation et leurs utilisations therapeutiques
BE834112A (fr) Derives de l'acide 2-naphtyl-butyrique a activite therapeutique
BE787403A (fr) Preparation de certains derives d'indolobenzazepine
NO139482C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfin- og norkodeinderivater

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: HENKEL K.G.A.A.

Effective date: 19941204